Rh Factor in Pregnancy: What Rh-Negative Mothers Need to Know

What Is the Rh Factor?

The Rh factor (Rhesus factor) refers to a specific protein on the surface of red blood cells called the Rh-D antigen. If your red cells carry this protein, you are Rh-positive (+). If they do not, you are Rh-negative (-). Approximately 85% of the US population is Rh-positive; around 15% is Rh-negative, according to the American Red Cross.

For most of everyday life, your Rh status is irrelevant to your health. It only becomes medically significant in two situations: blood transfusion and pregnancy. In both cases, the concern is whether your immune system encounters the Rh-D antigen for the first time and develops antibodies against it.

Rh-negative individuals who have never been exposed to Rh-positive blood produce no anti-D antibodies. But after exposure - either through an incompatible transfusion or fetal-maternal blood mixing during pregnancy - the immune system may become sensitised and produce anti-D antibodies that persist for life.

When Does Rh Factor Matter in Pregnancy?

Rh incompatibility becomes a concern when the mother is Rh-negative and the fetus is Rh-positive. This situation arises only when the father is Rh-positive - because the baby inherits Rh-D from the father. If the father is also Rh-negative, all children will be Rh-negative and there is no incompatibility risk.

During a normal pregnancy, fetal and maternal blood circulations are separate. However, a small amount of fetal blood typically crosses into the mother's circulation around the time of delivery. This exposure can sensitise an Rh-negative mother to Rh-D.

Sensitisation can also occur earlier during pregnancy following certain events: miscarriage, termination, amniocentesis, chorionic villus sampling (CVS), significant abdominal trauma, or ectopic pregnancy. In all these cases, anti-D prophylaxis is recommended.

Why First Pregnancies Are Usually Safe

In a first Rh-incompatible pregnancy, the small amount of fetal blood that enters the mother's circulation typically causes initial sensitisation - but the immune response takes time to develop. By the time anti-D antibodies form, the pregnancy is usually over and the baby has been born safely.

This delay is why Rh incompatibility rarely causes problems in a first pregnancy. It is the second and subsequent pregnancies with Rh-positive fetuses where the risk escalates: the mother's immune system is already primed. Pre-existing anti-D antibodies cross the placenta rapidly and can attack fetal red cells from early in the pregnancy.

Haemolytic Disease of the Newborn (HDN)

When maternal anti-D antibodies cross the placenta and attack fetal red cells, the result is haemolytic disease of the newborn (HDN), also called erythroblastosis fetalis. Severity ranges from mild anaemia and newborn jaundice to severe anaemia, hydrops fetalis (fluid accumulation throughout the fetal body), and in rare untreated cases, stillbirth.

Monitoring for Rh-sensitised pregnancies includes serial antibody titre measurements, and if levels are concerning, middle cerebral artery (MCA) Doppler ultrasound to assess fetal anaemia non-invasively. Severe cases may require intrauterine transfusion - a procedure where compatible blood is transfused directly into the fetal circulation through the umbilical vein.

Before anti-D prophylaxis was introduced in the 1960s, HDN affected 1 in 20-100 babies born to Rh-negative mothers with Rh-positive partners. Today, with routine prophylaxis, that rate has dropped below 1 in 1,000.

Anti-D Immunoglobulin (RhoGAM): How It Works

Anti-D immunoglobulin (marketed as RhoGAM in the US, and available as Rhophylac, WinRho, and NHS anti-D injections in other countries) works by neutralising any Rh-positive fetal cells that enter the mother's bloodstream before her immune system has time to recognise and respond to them.

The standard US protocol, as described by Cleveland Clinic and ACOG guidelines:

• 28 weeks gestation: routine antenatal dose for all Rh-negative mothers
• Within 72 hours of delivery: dose given if baby is confirmed Rh-positive
• After any sensitising event: miscarriage, termination, ectopic pregnancy, amniocentesis, CVS, or significant abdominal trauma
• If the baby's Rh type is unknown at delivery, anti-D is given as a precaution

Anti-D immunoglobulin does not harm the fetus and is safe during pregnancy. It only works as prevention - once sensitisation has occurred, anti-D cannot reverse it. This is why timing is critical and missed doses should be reported to a clinician immediately.

Pregnancy Rh Compatibility Table

Frequently Asked Questions